Review: could Tamoxifen Citrate cause Lymphoma?


Lymphoma is found among people who take Tamoxifen Citrate, especially for people who are female, 60+ old , have been taking the drug for 2 - 5 years, also take medication Lasix, and have Atrial fibrillation . We study 8,740 people who have side effects while taking Tamoxifen citrate from FDA and social media. Among them, 32 have Lymphoma. Find out below who they are, when they have Lymphoma and more.

You are not alone

Join a support group for people who take Tamoxifen citrate and have Lymphoma >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>

Tamoxifen Citrate

Tamoxifen citrate has active ingredients of tamoxifen citrate. It is often used in breast cancer. (latest outcomes from Tamoxifen citrate 9,091 users)


Lymphoma (cancer that begins in immune system cells) has been reported by people with breathing difficulty, death, renal failure acute, sepsis, febrile neutropenia (latest reports from 10,994 Lymphoma patients).

On Aug, 26, 2016

8,740 people reported to have side effects when taking Tamoxifen Citrate.
Among them, 32 people (0.37%) have Lymphoma

Number of reports submitted per year:

Could Tamoxifen citrate cause Lymphoma?

Time on Tamoxifen Citrate when people have Lymphoma *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 100 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Lymphoma when taking Tamoxifen Citrate *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Lymphoma when taking Tamoxifen Citrate *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 24.14 %
  • 50-59: 3.45 %
  • 60+: 72.41 %

Top conditions involved for these people *:

  • Atrial Fibrillation (13 people)
  • Breast Cancer (9 people)
  • Cardiac Failure Congestive (8 people)
  • Oral Disorder (7 people)
  • Eczema (7 people)

Top co-used drugs for these people *:

  • Tylenol-500 (14 people)
  • Neulasta (14 people)
  • Lasix (14 people)
  • Ativan (13 people)
  • Prochlorperazine (12 people)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Lymphoma when taking Tamoxifen citrate?

Browse all side effects of Tamoxifen citrate

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Lymphoma


Could your condition cause Lymphoma


Can you answer these questions?

More questions for: Tamoxifen citrate, Lymphoma

You may be interested in these reviews

More reviews for: Tamoxifen citrate, Lymphoma

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.